advertisement
Abstract #25397 Published in IGR 12-1
Advance in the study of complication of anti-vascular endothelial growth factor following intravitreal injection
Meng L; Chen SChinese Ophthalmic Research 2009; 27: 1039-1043
The efficacy of intravitreal injection of anti vascular endothelial growth factor(VEGF) drug has been recognized for the treatment of choroidal neovascularization(CNV) secondary to age-related macular degeneration(AMD), central exudative chorioretinopathy and pathological myopia, proliferative diabetic retinopathy (PDR), retinal vein occlusion, retinopathy of prematurity and neovascular glaucoma. The tendency of clinic application of anti-VEGF is increasing. Though the therapeutic effect of anti-VEGF has been confirmed, a variety of complications associated with its usage were reported. This review summared the advancement of the complication in the clinical application of anti-VEGF therapy such as its effect on normal structure and physiological function of eye, intraocular pressure elevation, rips of retinal pigment epithelium(RRPE), retinal detachment(RD), endophthalmitis and systemic side-effects. LA: Chinese
L. Meng. Clinical College of Ophthalmology, Tianjin Medical University, Tianjin Institute of Ophthalmology, Tianjin 300020, China.
Classification:
11.15 Other drugs in relation to glaucoma (Part of: 11 Medical treatment)
12.8.11 Complications, endophthalmitis (Part of: 12 Surgical treatment > 12.8 Filtering surgery)
